C-3 sterol dehydrogenase%3B catalyzes the second of three steps required to remove two C-4 methyl groups from an intermediate in ergosterol biosynthesis%3B human homolog NSDHL implicated in CK syndrome%2C and can complement yeast null mutant%3B molecular target of natural product and antifungal compound FR171456
